DAVIDSON KEMPNER CAPITAL MANAGEMENT LP - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is and the CUSIP is 29664WAB1. A total of 22 filers reported holding ESPERION THERAPEUTICS INC NE in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q3 2023$16,016,500
+6.0%
31,100,000
+0.2%
0.25%
-19.6%
Q2 2023$15,106,073
+60.1%
31,025,000
+24.1%
0.32%
+97.5%
Q1 2023$9,432,500
+69770.4%
25,000,0000.0%0.16%
+7900.0%
Q4 2022$13,500
-99.9%
25,000,000
+4.2%
0.00%
-99.2%
Q3 2022$13,275,000
+1.7%
24,000,0000.0%0.24%
+7.5%
Q2 2022$13,050,000
+7.5%
24,000,0000.0%0.23%
+44.9%
Q1 2022$12,135,000
-3.2%
24,000,0000.0%0.16%
-15.7%
Q4 2021$12,540,00024,000,0000.18%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q2 2022
NameSharesValueWeighting ↓
PenderFund Capital Management Ltd. 17,454,000$9,8263.09%
Affinity Asset Advisors, LLC 7,500,000$3,008,2500.99%
DCF Advisers, LLC 3,600,000$1,476,0000.90%
Context Capital Management, LLC 21,851$8,7640.74%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 32,000,000$13,1200.48%
SILVERBACK ASSET MANAGEMENT LLC 6,250,000$2,500,0000.34%
WHITEBOX ADVISORS LLC 20,600,000$8,159,6600.28%
TENOR CAPITAL MANAGEMENT Co., L.P. 26,425,000$11,431,7480.23%
READYSTATE ASSET MANAGEMENT LP 5,500,000$2,206,0500.20%
DAVIDSON KEMPNER PARTNERS 25,000,000$9,432,5000.18%
View complete list of ESPERION THERAPEUTICS INC NE shareholders